CASTOR OIL

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT CASTOR OIL

Composition:

Active substance: castor oil;

1 vial contains 30 ml, 50 ml, or 100 ml of castor oil.

Pharmaceutical form. Oil.

Main physico-chemical properties: clear, viscous liquid, colorless or slightly yellowish, with a faint odor and a characteristic, unpleasant taste. In thin layers, exposed to air, it slowly thickens but does not form a dense or solid film.

Pharmacotherapeutic group.

Purgative agent. ATC code A06AB05.

Pharmacological properties.

Pharmacodynamics.

When administered orally, it is hydrolyzed by lipase in the small intestine to form ricinoleic acid, which irritates intestinal receptors and reflexively enhances intestinal peristalsis. Laxative effect usually occurs within 5–6 hours. The drug also causes reflex contraction of the myometrium.

Pharmacokinetics.

Pharmacokinetics has not been determined.

Clinical characteristics.

Indications.

Constipation.

Contraindications.

Hypersensitivity to the drug; hypersensitivity to plants of the spurge family (Euphorbiaceae); poisoning with fat-soluble substances (phosphorus, benzene, phenol); peptic ulcer of the stomach and duodenum, ulcerative colitis; poisoning with fat-soluble anthelmintics, male fern extract; acute inflammatory conditions in the abdominal cavity (appendicitis, peritonitis); uterine bleeding; cachexia; advanced age; undiagnosed abdominal pain; biliary tract obstruction; severe dehydration.

Interaction with other medicinal products and other forms of interaction.

Concurrent use of Castor Oil with male fern extract is not recommended.

Instructions for use

Castor oil is a traditional herbal medicinal product for use according to indications, supported by long-standing use.

Do not violate the instructions for use of the medicinal product, as this may harm your health.

Use during pregnancy or breastfeeding.

Use of the medicinal product is contraindicated during pregnancy.

During breastfeeding, the product should be used only if the expected benefit to the mother outweighs the potential risk to the infant.

Ability to influence reaction rate while driving or operating machinery.

No data available.

Dosage and Administration.

For oral use.

The recommended dose for adults and children aged 12 years and older is 15–30 ml per dose.

If the medicinal product is used for bowel cleansing prior to diagnostic procedures, it should be administered 6 hours before the procedure.

If symptoms of illness do not resolve during treatment with the medicinal product or if any adverse reactions occur, the patient should consult a physician.

Children.

This medicinal product is intended for use in children aged 12 years and older.

Overdose.

Symptoms: nausea, vomiting, abdominal pain, diarrhea.

Treatment: symptomatic therapy.

Side effects.

Nausea, vomiting, diarrhea, abdominal pain, water-electrolyte imbalance. After bowel evacuation, constipation may occur. With prolonged use – digestive disturbances, enterocolitis, development of dependence, intestinal atony.

Allergic reactions are possible.

Shelf life. 5 years.

Storage conditions.

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging.

30 ml, 50 ml, 100 ml in glass or polymer bottles.

Prescription status. Over-the-counter.

Manufacturer.

JSC «Lubnipharm».

Manufacturer's address and location of business activity.

16 Barvinkova Street, Lubny, Poltava Oblast, 37500, Ukraine.